Evidence map›Paper›PMID 41939878›Full record

ArticleFrontiers in immunology2026

Dynamic progression of ectopic lymphoid structure formation in lacrimal glands of a Sjögren's disease murine model.

Sara Abdelhamid, Alison V Ramirez, Emre Aksan, Elizaveta A Demianova, Cintia S de Paiva, Maria C Edman, J Andrew MacKay, Sarah F Hamm-Alvarez

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara AbdelhamidDepartment of Pharmacology and Pharmaceutical Sciences, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.
Alison V RamirezDepartment of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Emre AksanOcular Surface Center, Department of Ophthalmology, Baylor College of Medicine, Houston, TX, United States.
Elizaveta A DemianovaOcular Surface Center, Department of Ophthalmology, Baylor College of Medicine, Houston, TX, United States.
Cintia S de PaivaOcular Surface Center, Department of Ophthalmology, Baylor College of Medicine, Houston, TX, United States.
Maria C EdmanDepartment of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
J Andrew MacKayDepartment of Pharmacology and Pharmaceutical Sciences, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.
Sarah F Hamm-AlvarezDepartment of Pharmacology and Pharmaceutical Sciences, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.

Funding

Ophthalmic Therapeutics Engineering CoreP30EY029220 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Mahnaz Shahidi · 2018 to 2026
$6.5M
Protein-polymer nanomedicine for Sjogren's SyndromeR01EY026635 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Sarah F Hamm-Alvarez, John Andrew MacKay · 2017 to 2026
$4.6M
NEI NIH HHS P30 EY029220NEI NIH HHS R01 EY026635
6 · The paper itself

Abstract

Background: Sjögren's Disease (SjD) is a chronic autoimmune condition characterized by lymphocytic infiltration of lacrimal glands (LG) and salivary glands (SG). In SG, these immune structures have properties of ectopic lymphoid structures (ELS) and appear to play a critical role in disease pathology. While the presence of ELS in patients' SG biopsies is linked to disease severity, their presence and composition in LG has not been well characterized. Methods: The properties and time course of apparent ELS development in LG from the male non-obese diabetes free (NOR) sub-strain of the Non-Obese Diabetic (NOD) mice was investigated at stages encompassing early to advanced lymphocytic infiltration. LG ELS were characterized morphologically by histology and immunofluorescence. Changes in LG gene expression were determined for genes involved in ELS formation and maturation, LG homeostasis and LG apoptosis. Results: LG ELS were characterized by segregation of B and T cell zones and the presence of high endothelial venules, follicular dendritic centers, GL7+ germinal center B cells, and IgG producing plasma cells. Gene expression data showed early upregulation of ELS indicators such as Conclusion: ELS form spontaneously in the LG of the male NOR mouse model of SjD and can recapitulate features of secondary lymphoid organs potentially acting as drivers of autoimmunity to sustain local glandular disease.

Indexed as

Lacrimal ApparatusSjogren's SyndromeTertiary Lymphoid StructuresAnimalsApoptosisDisease Models, AnimalDisease ProgressionMaleMiceMice, Inbred NODapoptosisautoimmune diseaseectopic lymphoid structuresferroptosislacrimal glandsecondary lymphoid organsSjögrens disease

Identifiers

PMID41939878
PMCPMC13044039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.